Skip to main content
Top
Published in: Digestive Diseases and Sciences 9/2007

01-09-2007 | ORIGINAL ARTICLE

Influence of Radiofrequency Energy Delivery at the Gastroesophageal Junction (the Stretta Procedure) on Symptoms, Acid Exposure, and Esophageal Sensitivity to Acid Perfusion in Gastroesophagal Reflux Disease

Authors: J. Arts, D. Sifrim, P. Rutgeerts, A. Lerut, J. Janssens, J. Tack

Published in: Digestive Diseases and Sciences | Issue 9/2007

Login to get access

Abstract

Several studies have demonstrated that radiofrequency energy delivery at the gastroesophageal junction (the Stretta procedure) induces symptom relief in gastroesophageal reflux disease (GERD), although improvement of acid exposure on pH monitoring was usually limited. A role for decreased esophageal sensitivity has been suggested. Our aim was to evaluate the influence of Stretta on symptoms, acid exposure, and sensitivity to esophageal acid perfusion in GERD. Thirteen patients with established proton pump inhibitor (PPI)-dependent GERD (three males; mean age, 51±10 years) participated in the study. Before and 6 months after the procedure symptom score, pH monitoring and Bernstein acid perfusion test were performed. The latter was done by infusing HCl (pH 0.1) at a rate of 6 ml/min 15 cm proximal to the gastroesophageal junction for a maximum of 30 min or until the patients experienced heartburn. Results were compared by Student’s t-test. Stretta procedure time was 51±4 min and no complications occurred. After 6 months, the symptom score was significantly improved (12.5±2.0 to 7.5±2.1; P<0.05), seven patients no longer needed daily PPI, and acid exposure was significantly decreased (11.6%±1.6% to 8.5%±1.8% of time pH<4; P<0.05). The time needed to induce heartburn during acid perfusion decreased from 9.5±2.3 to 18.1±3.4 min (P=0.01), and five patients became insensitive to 30-min acid perfusion, versus none at baseline (P=0.04). In conclusion, the Stretta procedure induces subjective improvement of GERD symptoms and decreases esophageal acid exposure. In addition, esophageal acid sensitivity is decreased 6 months after the Stretta procedure. The mechanism underlying this finding and its relevance to symptom control require further studies.
Literature
1.
go back to reference Wienbeck M, Barnert J (1989) Epidemiology of reflux disease and reflux esophagitis. Scand J Gastroenterol 24 (Suppl 56):7–13 Wienbeck M, Barnert J (1989) Epidemiology of reflux disease and reflux esophagitis. Scand J Gastroenterol 24 (Suppl 56):7–13
2.
go back to reference Locke GR 3rd, Talley NG, Fett SL, Zinsmmeister AR, Melton LJ 3rd (1997) Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County. Gastroenterology 112:1448–1456PubMedCrossRef Locke GR 3rd, Talley NG, Fett SL, Zinsmmeister AR, Melton LJ 3rd (1997) Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County. Gastroenterology 112:1448–1456PubMedCrossRef
3.
go back to reference Lagergren J, Bergström R, Lindgren A, Nyren O (1999) Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 340:825–831PubMedCrossRef Lagergren J, Bergström R, Lindgren A, Nyren O (1999) Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 340:825–831PubMedCrossRef
4.
go back to reference Bardhan KD (1999) The role of proton pomp inhibitors in the treatment of gastroesophageal reflux disease. Aliment Pharmacol Ther Suppl 1:15–25 Bardhan KD (1999) The role of proton pomp inhibitors in the treatment of gastroesophageal reflux disease. Aliment Pharmacol Ther Suppl 1:15–25
5.
go back to reference Leite L, Johnston B, Just R, Castell D (1996) Persistent acid secretion during omeprazole therapy: a study of gastric acid profiles in patients demonstrating failure of omeprazole therapy. Am J Gastroenterol 91(8):1527–1531PubMed Leite L, Johnston B, Just R, Castell D (1996) Persistent acid secretion during omeprazole therapy: a study of gastric acid profiles in patients demonstrating failure of omeprazole therapy. Am J Gastroenterol 91(8):1527–1531PubMed
6.
go back to reference Beldi G, Glattli A (2002). Long-term gastrointestinal symptoms after laparoscopic Nissen fundoplication. Surg Laparosc Endosc Percutan Techn 12(5):316–319CrossRef Beldi G, Glattli A (2002). Long-term gastrointestinal symptoms after laparoscopic Nissen fundoplication. Surg Laparosc Endosc Percutan Techn 12(5):316–319CrossRef
7.
go back to reference Lundell L (2002) Protagonist. Laparoscopic fundoplication is the treatment of choice for gastro-oesophageal reflux disease. Gut 51:468–472PubMedCrossRef Lundell L (2002) Protagonist. Laparoscopic fundoplication is the treatment of choice for gastro-oesophageal reflux disease. Gut 51:468–472PubMedCrossRef
8.
go back to reference Galmiche J, Zerbib F (2002) Antagonist. Laparoscopic fundoplication is the treatment of choice for gastro-oesophageal reflux disease. Gut 51:472–272PubMedCrossRef Galmiche J, Zerbib F (2002) Antagonist. Laparoscopic fundoplication is the treatment of choice for gastro-oesophageal reflux disease. Gut 51:472–272PubMedCrossRef
9.
go back to reference Spechler SJ, Lee E, Ahnen D, Goyal RK, Hirano I, Ramirez F, Raufmann JP, Sampliner R, Schnell T, Sontag S, Vlahcevic ZR, Young R, Williford W (2000) Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease. JAMA 285(18):2331–2338CrossRef Spechler SJ, Lee E, Ahnen D, Goyal RK, Hirano I, Ramirez F, Raufmann JP, Sampliner R, Schnell T, Sontag S, Vlahcevic ZR, Young R, Williford W (2000) Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease. JAMA 285(18):2331–2338CrossRef
10.
go back to reference Vakil N, Shaw M, Kirby R (2003) Clinical effectiveness of laparoscopic fundoplication in a U.S. community. Am J Med 114:1–5PubMedCrossRef Vakil N, Shaw M, Kirby R (2003) Clinical effectiveness of laparoscopic fundoplication in a U.S. community. Am J Med 114:1–5PubMedCrossRef
11.
go back to reference Utley DS, Kim M, Vierra MA, Triadafilopoulos G (2000) Augmentation of lower esophageal sphincter pressure and gastric yield pressure after radiofrequency energy delivery to the gastroesophageal junction: a porcine model. Gastrointest Endosc 52:81–86PubMedCrossRef Utley DS, Kim M, Vierra MA, Triadafilopoulos G (2000) Augmentation of lower esophageal sphincter pressure and gastric yield pressure after radiofrequency energy delivery to the gastroesophageal junction: a porcine model. Gastrointest Endosc 52:81–86PubMedCrossRef
12.
go back to reference Triadafilopoulos G, DiBaise JK, Nostrant TT, Stollman NH (2002) The Stretta procedure for the treatment of GERD: 6 and 12 month follow-up of the U.S. open label trial. Gastrointest Endosc 55(2):149–156PubMedCrossRef Triadafilopoulos G, DiBaise JK, Nostrant TT, Stollman NH (2002) The Stretta procedure for the treatment of GERD: 6 and 12 month follow-up of the U.S. open label trial. Gastrointest Endosc 55(2):149–156PubMedCrossRef
13.
go back to reference DiBaise JK, Brand RE, Quigley EM (2002) Endoluminal delivery of radiofrequency energy to the gastroesophageal junction in uncomplicated GERD: efficacy and potential mechanism of action. Am J Gastroenterol 97(4):833–842PubMedCrossRef DiBaise JK, Brand RE, Quigley EM (2002) Endoluminal delivery of radiofrequency energy to the gastroesophageal junction in uncomplicated GERD: efficacy and potential mechanism of action. Am J Gastroenterol 97(4):833–842PubMedCrossRef
14.
go back to reference Corley DA, Katz P, Wo J, et al. (2003) Temperature controlled radiofrequency energy delivery to the gastroesophageal junction for the treatment of GERD (the Stretta procedure): a randomized, double-blind, sham controlled, multi-center clinical trial. Gastroenterology 125:668–676PubMedCrossRef Corley DA, Katz P, Wo J, et al. (2003) Temperature controlled radiofrequency energy delivery to the gastroesophageal junction for the treatment of GERD (the Stretta procedure): a randomized, double-blind, sham controlled, multi-center clinical trial. Gastroenterology 125:668–676PubMedCrossRef
15.
go back to reference Houston H, Khaitan L, Holzman M, Richards WO (2003) First year experience of patients undergoing the stretta procedure. Surg Endosc 17:401–404PubMedCrossRef Houston H, Khaitan L, Holzman M, Richards WO (2003) First year experience of patients undergoing the stretta procedure. Surg Endosc 17:401–404PubMedCrossRef
16.
go back to reference Kim MS, Holloway RH, Dent J, Utley DS (2003) Radiofrequency energy delivery to the gastric cardia inhibits triggering of transient lower esophageal sphincter relaxation and gastroesophageal reflux in dogs. Gastrointest Endosc 57(1):17–22PubMedCrossRef Kim MS, Holloway RH, Dent J, Utley DS (2003) Radiofrequency energy delivery to the gastric cardia inhibits triggering of transient lower esophageal sphincter relaxation and gastroesophageal reflux in dogs. Gastrointest Endosc 57(1):17–22PubMedCrossRef
17.
go back to reference Tam W, Schoeman M, Zhang Q, Dent J, Rigda R, Utley D, Holloway R (2003) Delivery of radiofrequency energy to the lower esophageal sphincter and the gastric cardia inhibits transient lower esophageal sphincter relaxations and gastroesophageal reflux in patients with reflux disease. Gut 52:479–485PubMedCrossRef Tam W, Schoeman M, Zhang Q, Dent J, Rigda R, Utley D, Holloway R (2003) Delivery of radiofrequency energy to the lower esophageal sphincter and the gastric cardia inhibits transient lower esophageal sphincter relaxations and gastroesophageal reflux in patients with reflux disease. Gut 52:479–485PubMedCrossRef
18.
go back to reference Kahrilas P (2003) Radiofrequency energy treatment of GERD. Gastroenterology 25:970–973CrossRef Kahrilas P (2003) Radiofrequency energy treatment of GERD. Gastroenterology 25:970–973CrossRef
19.
go back to reference Howard PJ, Maher L, Pryde A, Heading RC (1991) Symptomatic gastro-oesophageal reflux, abnormal oesophageal acid exposure, and mucosal acid sensitivity are three separate, though related, aspects of gastro-oesophageal reflux disease. Gut 32:128–132PubMed Howard PJ, Maher L, Pryde A, Heading RC (1991) Symptomatic gastro-oesophageal reflux, abnormal oesophageal acid exposure, and mucosal acid sensitivity are three separate, though related, aspects of gastro-oesophageal reflux disease. Gut 32:128–132PubMed
20.
go back to reference Shi G, Bruley des Varannes S, Scarpignato C, Le Rhun M, Galmiche JP (1995) Reflux-related symptoms in patients with normal oesophageal exposure to acid. The acid hypersensitive oesophagus. Gut 37:457–464PubMed Shi G, Bruley des Varannes S, Scarpignato C, Le Rhun M, Galmiche JP (1995) Reflux-related symptoms in patients with normal oesophageal exposure to acid. The acid hypersensitive oesophagus. Gut 37:457–464PubMed
21.
go back to reference Rodriguez-Stanley S, Earnest DL, Greenwood-Van Meerveld B, Maton P, Miner PB, Robinson M (1999) Esophageal hypersensitivity may be a major cause of heartburn. Am J Gastroenterol 94:628–631PubMedCrossRef Rodriguez-Stanley S, Earnest DL, Greenwood-Van Meerveld B, Maton P, Miner PB, Robinson M (1999) Esophageal hypersensitivity may be a major cause of heartburn. Am J Gastroenterol 94:628–631PubMedCrossRef
22.
go back to reference Savary M, Miller G (1977) L’oesophage. Manuel et Atlas d’Endoscopie. Verlag Gassmann, Solothurn Savary M, Miller G (1977) L’oesophage. Manuel et Atlas d’Endoscopie. Verlag Gassmann, Solothurn
23.
go back to reference Koek GH, Sifrim D, Lerut T, Janssens J, Tack J (2003) The effect of the GABAb agonist baclofen in patients with symptoms and duodenogastro-esophageal reflux refractory to proton pump inhibitors. Gut 10:1397–1402CrossRef Koek GH, Sifrim D, Lerut T, Janssens J, Tack J (2003) The effect of the GABAb agonist baclofen in patients with symptoms and duodenogastro-esophageal reflux refractory to proton pump inhibitors. Gut 10:1397–1402CrossRef
24.
go back to reference Tack J, Bisschops R, Koek GH, Sifrim D, Lerut A, Janssens J (2003) Dietary restrictions during ambulatory monitoring of duodeno-gastro-esophageal reflux. Dig Dis Sci 48:1213–1220PubMedCrossRef Tack J, Bisschops R, Koek GH, Sifrim D, Lerut A, Janssens J (2003) Dietary restrictions during ambulatory monitoring of duodeno-gastro-esophageal reflux. Dig Dis Sci 48:1213–1220PubMedCrossRef
25.
go back to reference Lord SM, Bogduk N (2002) Radiofrequency procedures in chronic pain. Best Pract Res Clin Anaesthesiol 16:597–617PubMedCrossRef Lord SM, Bogduk N (2002) Radiofrequency procedures in chronic pain. Best Pract Res Clin Anaesthesiol 16:597–617PubMedCrossRef
26.
go back to reference Kertes P, Kalman J, Edis B, Chen JM, Byrgiotis S, Kelly P, Tonkin A, Wilkinson J (1993) Radiofrequency catheter ablation of tachyarrhythmias–adult and paediatric experience. Aust NW J Med 23:426–432 Kertes P, Kalman J, Edis B, Chen JM, Byrgiotis S, Kelly P, Tonkin A, Wilkinson J (1993) Radiofrequency catheter ablation of tachyarrhythmias–adult and paediatric experience. Aust NW J Med 23:426–432
27.
go back to reference Sarkar S, Aziz Q, Woolf CJ, Hobson AR, Thompson DG (2000) Contribution of central sensitisation to the development of non-cardiac chest pain. Lancet 356(9236):1154–1159PubMedCrossRef Sarkar S, Aziz Q, Woolf CJ, Hobson AR, Thompson DG (2000) Contribution of central sensitisation to the development of non-cardiac chest pain. Lancet 356(9236):1154–1159PubMedCrossRef
28.
go back to reference Fass R, Naliboff B, Higa L, Johnson C, Kodner A, Munakata J, Ngo J, Mayer E (1998) Differential effect of long-term esophageal acid exposure on mechanosensitivity and chemosensitivity in humans. Gastroenterology 115:1363–1373PubMedCrossRef Fass R, Naliboff B, Higa L, Johnson C, Kodner A, Munakata J, Ngo J, Mayer E (1998) Differential effect of long-term esophageal acid exposure on mechanosensitivity and chemosensitivity in humans. Gastroenterology 115:1363–1373PubMedCrossRef
29.
go back to reference Orlando RC (2006) Current understanding of the mechanisms of gastro-oesophageal reflux disease. Drugs 66 (Suppl 1):1–5PubMedCrossRef Orlando RC (2006) Current understanding of the mechanisms of gastro-oesophageal reflux disease. Drugs 66 (Suppl 1):1–5PubMedCrossRef
30.
go back to reference Tobey NA, Carson JL, Alkiek RA, Orlando RC (1996) Dilated intercellular spaces: a morphological feature of acid reflux—damaged human esophageal epithelium. Gastroenterology 111(5):1200–1205PubMedCrossRef Tobey NA, Carson JL, Alkiek RA, Orlando RC (1996) Dilated intercellular spaces: a morphological feature of acid reflux—damaged human esophageal epithelium. Gastroenterology 111(5):1200–1205PubMedCrossRef
31.
go back to reference Caviglia R, Ribolsi M, Maggiano N, Gabbrielli AM, Emerenziani S, Guarino MP, Carotti S, Habib FI, Rabitti C, Cicala M (2005) Dilated intercellular spaces of esophageal epithelium in nonerosive reflux disease patients with physiological esophageal acid exposure. Am J Gastroenterol 100:543–548PubMedCrossRef Caviglia R, Ribolsi M, Maggiano N, Gabbrielli AM, Emerenziani S, Guarino MP, Carotti S, Habib FI, Rabitti C, Cicala M (2005) Dilated intercellular spaces of esophageal epithelium in nonerosive reflux disease patients with physiological esophageal acid exposure. Am J Gastroenterol 100:543–548PubMedCrossRef
32.
go back to reference Calabrese C, Bortolotti M, Fabbri A, Areni A, Cenacchi G, Scialpi C, Miglioli M, Di Febo G (2005) Reversibiility of GERD ultrastructural alterations and relief of symptoms after omeprazole treatment. Am J Gastroenterol 100:537–542PubMedCrossRef Calabrese C, Bortolotti M, Fabbri A, Areni A, Cenacchi G, Scialpi C, Miglioli M, Di Febo G (2005) Reversibiility of GERD ultrastructural alterations and relief of symptoms after omeprazole treatment. Am J Gastroenterol 100:537–542PubMedCrossRef
33.
go back to reference Matthews PJ, Aziz Q, Facer P, Davis JB, Thompson DG, Anand P (2004) Increased capsaicin receptor TRPV1 nerve fibres in the inflamed human oesophagus. Eur J Gastroenterol Hepatol 16:897–902PubMedCrossRef Matthews PJ, Aziz Q, Facer P, Davis JB, Thompson DG, Anand P (2004) Increased capsaicin receptor TRPV1 nerve fibres in the inflamed human oesophagus. Eur J Gastroenterol Hepatol 16:897–902PubMedCrossRef
Metadata
Title
Influence of Radiofrequency Energy Delivery at the Gastroesophageal Junction (the Stretta Procedure) on Symptoms, Acid Exposure, and Esophageal Sensitivity to Acid Perfusion in Gastroesophagal Reflux Disease
Authors
J. Arts
D. Sifrim
P. Rutgeerts
A. Lerut
J. Janssens
J. Tack
Publication date
01-09-2007
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 9/2007
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-006-9695-y

Other articles of this Issue 9/2007

Digestive Diseases and Sciences 9/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.